Susan H. Tannenbaum - Publications

Racial Disparities in Pathologic Complete Response and Survival after Neoadjuvant Chemotherapy for Breast Cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: April 11, 2025

Clinical Trial Diversity: A Bend in the Arc Toward Justice.

Journal: JCO precision oncology

Published: September 19, 2023

Qualitative Assessment of Perceived Organizational Support for Employed Breast Cancer Survivors.

Journal: Journal of occupational and environmental medicine

Published: July 25, 2023

Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy - a prospective analysis.

Journal: Cardio-oncology (London, England)

Published: January 11, 2023

Perceptions of clinical support for employed breast cancer survivors managing work and health challenges.

Journal: Journal of cancer survivorship : research and practice

Published: July 14, 2020

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence.

Journal: Scientific reports

Published: October 24, 2018

Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters.

Journal: Breast cancer research : BCR

Published: October 31, 2017

Treatment of Male Breast Cancer by Dual Human Epidermal Growth Factor Receptor 2 (HER2) Blockade and Response Prediction Using Novel Optical Tomography Imaging: A Case Report.

Journal: Cureus

Published: September 26, 2017

Effect of Adjuvant Chemotherapy on Left Ventricular Remodeling in Women with Newly Diagnosed Primary Breast Cancer: A Pilot Prospective Longitudinal Cardiac Magnetic Resonance Imaging Study.

Journal: Journal of thoracic imaging

Published: July 11, 2017

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial.

Journal: NPJ breast cancer

Published: July 21, 2016

Late recurrence of gastric cancer with isolated brain metastasis.

Journal: Translational gastroenterology and hepatology

Published: June 22, 2016

Metastatic Inflammatory Breast Cancer Associated With Multicentric Reticulohistiocytosis Successfully Treated With Zoledronic Acid.

Journal: Clinical breast cancer

Published: March 08, 2016